Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Laboratory Corp. of America Holdings    LH

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Laboratory Corp. of America Holdings : LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/13/2012 | 10:05pm CET

Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today that for the period of March 12, 2012 to September 11, 2012, its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) will, subject to the terms of the Zero Coupon Notes, accrue contingent cash interest at a rate of no less than 0.125% of the average market price of a Zero Coupon Note for the five trading days ended March 7, 2012, in addition to the continued accrual of the original issue discount. Contingent cash interest, which the Company has determined to be approximately $1.50 per Note, will be payable to holders of the Zero Coupon Notes as of the record date, which is August 26, 2012. The payment of contingent cash interest is expected to be made on September 11, 2012.

About LabCorp®

Laboratory Corporation of America® Holdings, an S&P 500 company, is a pioneer in commercializing new diagnostic technologies and the first in its industry to embrace genomic testing. With annual revenues of $5.5 billion in 2011, over 31,000 employees worldwide, and more than 220,000 clients, LabCorp offers more than 4,000 tests ranging from routine blood analyses to reproductive genetics to companion diagnostics. LabCorp furthers its scientific expertise and innovative clinical testing technology through its specialized labs and the LabCorp Specialty Testing Group: The Center for Molecular Biology and Pathology, National Genetics Institute, ViroMed Laboratories, Inc., The Center for Esoteric Testing, Litholink Corporation, Integrated Genetics, Integrated Oncology, DIANON Systems, Inc., Monogram Biosciences, Inc., Colorado Coagulation, and Endocrine Sciences. LabCorp conducts clinical trials testing through its Esoterix Clinical Trials Services. LabCorp clients include physicians, government agencies, managed care organizations, hospitals, clinical labs, and pharmaceutical companies. To learn more about our organization, visit our Web site at: www.labcorp.com.

This press release contains forward-looking statements. Each of the forward-looking statements is subject to change based on various important factors, including without limitation, competitive actions in the marketplace and adverse actions of governmental and other third-party payors. Actual results could differ materially from those suggested by these forward-looking statements. Further information on potential factors that could affect LabCorp's financial results is included in the Company's Form 10-K for the year ended December 31, 2011, and subsequent SEC filings.

LabCorp
Stephen Anderson, 336-436-5274
www.labcorp.com


© Business Wire 2012
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on LABORATORY CORP. OF AMERIC
03:36a LABORATORY OF AMERICA : Tri-Cities Laboratory future clouded by sale of part own..
02/27 LABORATORY OF AMERICA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDIT..
02/27 LABORATORY OF AMERICA : LabCorp buys lab company
02/24 LABORATORY OF AMERICA : LabCorp buying Spokane-based PAML
02/23 LABORATORY CORP OF AMERICA HOLDINGS : Regulation FD Disclosure (form 8-K)
02/23 LABORATORY OF AMERICA : LabCorp to Acquire Pathology Associates Medical Laborato..
02/19 LABCORP : Company reports record year
02/16 LABORATORY OF AMERICA : LabCorp tops Street 4Q forecasts
02/16 LABORATORY CORP OF AMERICA HOLDINGS : Regulation FD Disclosure (form 8-K)
02/16 LABORATORY CORP OF AMERICA HOLDINGS : Results of Operations and Financial Condit..
More news
Sector news : Healthcare Facilities & Services - NEC
02/23DJIHH HEALTHCARE BHD : Malaysia's IHH Healthcare Swings to Net Loss in 4th Quarter..
02/23DJIHH HEALTHCARE BHD : Malaysia's IHH Healthcare Swings to Loss in 4th Quarter
02/22DJFRESENIUS MEDICAL CARE : Profit Lifted by Strong U.S. Performance
02/21 HSBC pulls FTSE lower
02/20DJFRESENIUS : 4Q 2016 -- Forecast
More sector news : Healthcare Facilities & Services - NEC
News from SeekingAlpha
02/25 Broyhill Asset Management 2016 Annual Letter - Benchmark Envy
02/24 LabCorp to buy reference lab operations jointly owned by Providence Health an..
02/24 Tracking Larry Robbins' Glenview Capital Management Portfolio - Q4 2016 Updat..
02/23 Tracking Wallace Weitz's Weitz Investment Management Portfolio - Q4 2016 Upda..
02/16 Laboratory of America Holdings (LH) Q4 2016 Results - Earnings Call Transcrip..
Advertisement
Financials ($)
Sales 2017 9 931 M
EBIT 2017 1 614 M
Net income 2017 871 M
Debt 2017 4 644 M
Yield 2017 -
P/E ratio 2017 16,80
P/E ratio 2018 15,33
EV / Sales 2017 1,95x
EV / Sales 2018 1,79x
Capitalization 14 718 M
More Financials
Chart LABORATORY CORP. OF AMERIC
Duration : Period :
Laboratory Corp. of Americ Technical Analysis Chart | LH | US50540R4092 | 4-Traders
Full-screen chart
Technical analysis trends LABORATORY CORP. ...
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 154 $
Spread / Average Target 7,5%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
David P. King Chairman, President & Chief Executive Officer
Glenn A. Eisenberg Chief Financial Officer, Treasurer & Executive VP
Mark Elliott Brecher Chief Medical Officer & Senior Vice President
Lance V. Berberian Chief Information Officer & Senior Vice President
Marcia T. Eisenberg Chief Scientific Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
LABORATORY CORP. OF AM..11.30%14 718
HCA HOLDINGS INC17.63%32 624
FRESENIUS MEDICAL CARE..-3.00%25 195
QUEST DIAGNOSTICS INC5.89%13 491
DAVITA INC7.54%13 432
UNIVERSAL HEALTH SERVI..18.42%12 217
More Results